Aiming For More Deals, Shire Christens Regenerative Medicine Unit

The company hopes its newest division will mirror the growth of its rare disease unit, which was built largely through aggressive business development.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America